IL316053A - Preparations and methods for the treatment of solid cancer - Google Patents
Preparations and methods for the treatment of solid cancerInfo
- Publication number
- IL316053A IL316053A IL316053A IL31605324A IL316053A IL 316053 A IL316053 A IL 316053A IL 316053 A IL316053 A IL 316053A IL 31605324 A IL31605324 A IL 31605324A IL 316053 A IL316053 A IL 316053A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- solid cancer
- treating solid
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
- C12Y101/03004—Glucose oxidase (1.1.3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/02—Oxidoreductases acting on a peroxide as acceptor (1.11) with H2O2 as acceptor, one oxygen atom of which is incorporated into the product (1.11.2)
- C12Y111/02002—Myeloperoxidase (1.11.2.2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263330553P | 2022-04-13 | 2022-04-13 | |
| PCT/US2023/018289 WO2023200842A1 (en) | 2022-04-13 | 2023-04-12 | Compositions and methods for treating solid cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL316053A true IL316053A (en) | 2024-11-01 |
Family
ID=88330172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL316053A IL316053A (en) | 2022-04-13 | 2023-04-12 | Preparations and methods for the treatment of solid cancer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250332226A1 (https=) |
| EP (1) | EP4507793A1 (https=) |
| JP (1) | JP2025512366A (https=) |
| KR (1) | KR20250004257A (https=) |
| CN (1) | CN119677528A (https=) |
| AU (1) | AU2023252830A1 (https=) |
| CA (1) | CA3246603A1 (https=) |
| IL (1) | IL316053A (https=) |
| MX (1) | MX2024012316A (https=) |
| WO (1) | WO2023200842A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486408A (en) * | 1981-04-07 | 1984-12-04 | Kiel Johnathan L | Insoluble crosslinked cytotoxic oxidase-peroxidase system |
| WO1990003185A1 (en) * | 1988-09-28 | 1990-04-05 | Ideon Corporation | Combination enzyme immunotherapeutics |
| WO2007103525A2 (en) * | 2006-03-09 | 2007-09-13 | Glanbia Nutritionals (Ireland) Limited | Cationic whey protein composition |
| WO2013009910A2 (en) * | 2011-07-11 | 2013-01-17 | Exoxemis, Inc. | Eosinophil peroxidase compositions and methods of their use |
| WO2021202592A2 (en) * | 2020-03-30 | 2021-10-07 | Oregon Health & Science University | Monoclonal antibodies for intracellular delivery of payloads |
| CA3196357A1 (en) * | 2020-11-11 | 2022-05-19 | Robert C. Allen | Compositions and methods for treating solid cancer |
-
2023
- 2023-04-12 US US18/855,270 patent/US20250332226A1/en active Pending
- 2023-04-12 CN CN202380033790.0A patent/CN119677528A/zh active Pending
- 2023-04-12 AU AU2023252830A patent/AU2023252830A1/en active Pending
- 2023-04-12 WO PCT/US2023/018289 patent/WO2023200842A1/en not_active Ceased
- 2023-04-12 EP EP23788886.2A patent/EP4507793A1/en active Pending
- 2023-04-12 JP JP2024560262A patent/JP2025512366A/ja active Pending
- 2023-04-12 KR KR1020247037139A patent/KR20250004257A/ko active Pending
- 2023-04-12 IL IL316053A patent/IL316053A/en unknown
- 2023-04-12 CA CA3246603A patent/CA3246603A1/en active Pending
-
2024
- 2024-10-04 MX MX2024012316A patent/MX2024012316A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4507793A1 (en) | 2025-02-19 |
| AU2023252830A1 (en) | 2024-10-10 |
| WO2023200842A1 (en) | 2023-10-19 |
| CN119677528A (zh) | 2025-03-21 |
| KR20250004257A (ko) | 2025-01-07 |
| MX2024012316A (es) | 2024-11-08 |
| US20250332226A1 (en) | 2025-10-30 |
| JP2025512366A (ja) | 2025-04-17 |
| CA3246603A1 (en) | 2023-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286350A (en) | Preparations and methods for the treatment of cancer | |
| IL288914A (en) | Preparations and methods for the treatment of cancer | |
| ZA202104870B (en) | Methods and compositions for treating cancer | |
| IL315800A (en) | Preparations and methods for the treatment of cancer | |
| EP4025590A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CANCER | |
| SG11202109336UA (en) | Methods and compositions for treating cancer | |
| IL287982A (en) | Preparations and methods for the treatment of cancer | |
| IL286153A (en) | Methods and preparations for the treatment of cancer | |
| IL309120A (en) | Methods and compositions for the treatment of cancer | |
| IL309071A (en) | Methods and compositions for the treatment of cancer | |
| EP4077690A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CANCER | |
| IL308530A (en) | Preparations and methods for treating lung cancer | |
| EP4149508A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF CANCER | |
| IL319403A (en) | Compositions and methods for treating advanced solid tumors | |
| IL312846A (en) | Methods and preparations for the treatment of cancer | |
| EP4243835A4 (en) | COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER | |
| IL316053A (en) | Preparations and methods for the treatment of solid cancer | |
| IL319543A (en) | Cancer treatment compositions and methods | |
| IL285036A (en) | Methods and preparations for the treatment of cancer | |
| GB202402730D0 (en) | Methods and compositions for treating cancer | |
| CA3296990A1 (en) | Compositions and methods for treating cancer | |
| CA3291233A1 (en) | Methods and compositions for treating cancer | |
| CA3278391A1 (en) | Compositions and methods for treating cancer | |
| IL321784A (en) | Compositions and methods for treating alpha-synucleinopathies | |
| EP4518861A4 (en) | COMPOSITION AND METHOD OF CANCER TREATMENT |